Delivery Order SPE2DB22D2007-SPE2DB26FH6HJ
- Not listed
- The Defense Logistics Agency awarded a $3,004.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL, a contrast agent used in medical imaging procedures. This award, made on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a child order under a larger contract vehicle. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units) with a ceiling value of $4,126.40. This firm fixed-price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The award was...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL in 100 mL bottles with a ceiling value of $4,216.05 on August 29, 2025. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and carries no set-aside designation. The order was competitively awarded and represents a child contract under AmerisourceBergen's larger contract vehicle with the Defense Logistics Agency. AmerisourceBergen,...
- The Defense Logistics Agency awarded a $4,246.40 delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL infusion bottles (150 mL) on September 24, 2025, with completion expected by September 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line-item procurement of this contrast medium...
- The Defense Logistics Agency awarded a $1,650.56 delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml infusion bottles (150 ml) on September 25, 2025, with completion scheduled for September 26, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under the vendor's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,650.56 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml infusion bottles (150 ml) on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order, issued without a set-aside designation, was competitively awarded and represents a standard pharmaceutical procurement under the agency's medical supply chain operations. AmerisourceBergen Drug Corp, headquartered in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $10,053.00 firm fixed-price delivery order by the Defense Logistics Agency on June 17, 2025, for the supply of Visipaque 320 mg/ml in 100ml bottles. The contract is a non-set-aside competitive award with an ultimate completion date of June 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This $999,999,999.00 prime...
- The Defense Logistics Agency awarded a $5,006.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Visipaque 320 mg/ml in 100 ml bottles. This contract, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award for pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,296.38 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- On June 18, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,172.25 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in a 100 ml bottle. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open procurement process. The contract calls for completion by June 20, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6HJDelivery Order
The Defense Logistics Agency awarded a $2,503.35 delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Visipaque 320 mg/ml in 100ml bottles, a contrast medium used in medical imaging procedures. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), carries no set-aside designation and is scheduled for completion by October 15, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive Indefinite Delivery Contract to fulfill diverse medical supply requirements across multiple therapeutic domains. The company's DLA prime contract vehicle enables flexible delivery of brand-name and generic pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs globally, including services to the Defense Health Agency and U.S. Coast Guard. This particular delivery order exemplifies the routine pharmaceutical procurement activity executed under the broader contract framework, ensuring consistent availability of essential medical imaging supplies for federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 10/14/25 |